Weisser, Tamera M. Ph.D.

Current Employment Position(s)

Associate

Lawyer Overview

Dr. Tamera (Tammy) Weisser's practice includes domestic and foreign patent portfolio development, management, and enforcement in biotechnology, including immunology, biochemistry, molecular biology, pharmaceuticals, diagnostics, genetics, cell biology, stem cell therapy, gene therapy, and medical devices. Tammy has particularly extensive experience in the field of antibody technology and has represented clients such as Kyowa Hakko Kirin, MacroGenics, and MedImmune in developing their antibody portfolios. Other clients include Altair Therapeutics, Ambit Biosciences, BioMarin Pharmaceutical, BioSphere Medical, Celgene, Chembridge Research Laboratories, and Monogram Biosciences. Tammy also performs patent validity, noninfringement, and freedom-to-operate analyses and conducts due diligence of patent portfolios for potential investors, acquirers, and licensees, such as venture capital firms or pharmaceutical and biotechnology companies, including Apposite Capital, GeoSynFuels, and Mitsui Ventures.

Prior to joining Jones Day in 2004, Tammy spent five years as a patent agent at a large Washington, D.C. law firm. In addition, she was formerly a research scientist studying DNA-based vaccine technology at Agracetus, Inc. in Madison, Wisconsin and the Emory University Vaccine Research Center in Atlanta, Georgia.

In addition to her intellectual property practice, Tammy is part of the San Diego Office's recruiting committee and has been actively involved in organizing the summer associate program. She also mentors and supervises a number of less experienced associates. Tammy is an active member of a number of local professional organizations, including the San Diego County Bar Association, San Diego Intellectual Property Law Association, Athena San Diego, Association for Women in Science, Lawyers Club of San Diego, and Mother Attorneys Mentoring Association.

Areas of Practice

• Intellectual Property
• Patent Litigation
• Patent Prosecution
• Biotechnology
• Life Sciences
• Pharmaceuticals

Representative Cases

• Ambit Biosciences develops patent portfolio for small molecule kinase inhibitor programs
• Apposite Capital invests in Ambrx
• Arizeke Pharmaceuticals establishes patent portfolio for pIgR technology
• BioMarin establishes global patent portfolio for PAL technology
• BioSphere develops global patent portfolio for use of microspheres for tissue bulking
• BioSphere develops global patent portfolio related to polyvinyl alcohol microspheres , (2009)
• BioSphere develops patent portfolio for Quadrasphere® / Hepasphere®
• BioSphere establishes global patent portfolio related to microspheres for stem cell delivery
• BioSphere purchases assets from RJ Medical, Inc. , (2009)
• Celgene builds patent portfolio for E3 ubiquitin ligase technology
• Chembridge Research Labs develops patent portfolio for cell-free protein expression systems
• GeoSynFuels strikes joint venture with Donald Danforth Plant Science Center, establishes Agrius BioForms, LLC , (2009)
• Kirin Pharma Kabushiki Kaisha establishes patent portfolio for human LIGHT antibodies
• MacroGenics maintains patent portfolio for biologics, immunotherapeutics and cancer targets
• MedImmune establishes patent portfolio for Synagis® and Numax™
• Monogram Biosciences' maintains patent portfolio for medicine molecular diagnostics products , (2009)

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• California

Education

• Georgetown University
• U of Massachusetts - Worcester
• U of Wisconsin - Madison (Main

Published Works

• Th1 genetic adjuvants modulate immune responses in neonates, Vaccine. 19(13-14): 1764-1771, 2001
• DNA vaccines: Basic studies and applications, Advances in Virus Research, K. Maramorosch, F. Murphy, and A. Shatkin eds., Academic Press, New York, NY. 1-74, 2000
• DNA vaccines for influenza virus: Differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein, J. Virol., 74(17)7787-7793, 2000
• Characterization of immune responses following neonatal DNA immunization, University of Massachusetts Medical School, Doctoral Thesis, 2000
• Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein, Virology, 257(2):406-414, 1999
• Nucleic acid immunizations, in Current Protocols in Immunology, R. Coico ed., John Wiley and Sons, New York, NY. 2.14.1-2.14.19, 1998
• Influenza nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery, J. Virol, 70(9):6119-6125, 1996
• Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA, Vaccine, 13(15):1427-1430, 1995
• Accell® particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses, AIDS Res. Hum. Retroviruses, 10 Suppl. 2:S43-S45, 1994

Address

12265 El Camino Real Suite 200
San Diego, CA 92130-4096

Phones

1.858.314.1181 (Business Phone)

Faxes

1.858.314.1150 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com